🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The 13th nPOD Diabetes annual meeting took place last week, featuring some of the world's brightest T1D researchers. We have a recap over at the blog. jdrf.org/blog/2021/03/0…

BREAKING: The Bigfoot Unity™ Diabetes Management by Bigfoot Biomedical has received U.S. Food and Drug Administration clearance for individuals 12 and older. For the first time, people who use multiple daily injections (MDI) to manage their diabetes will be able to (1/2)

Life with T1D is tough. That's why JDRF is observing Mental Health Awareness Month and supporting psychosocial health issues in people with T1D through the JDRF Behavioral Health and Psychology Program. Learn more at the blog: jdrf.org/blog/2021/05/2…

JDRF applauds the U.S. Food and Drug Administration’s (FDA) Advisory Committee positive recommendation in support of approval of teplizumab for those at risk for developing clinical T1D. Learn more here: ow.ly/kt0f50EXfnB

We are proud to announce that Kevan Herold, M.D., C.N.H., Long Professor of Immunobiology and professor of medicine at Yale University, has been named chair of Type 1 Diabetes TrialNet. Congratulations, Dr. Herold! trialnet.org/events-news/bl… NIDDK

JDRF Vice President of Research, Sanjoy Dutta, Ph.D., congratulates Kevan Herald, M.D. on his appointment as the new TrialNet Chair. Read more: jdrf.org/press-releases…

At 1pm ET JDRF's Vice President of Research, Dr. Sanjoy Dutta will be giving a preview of what you can expect to learn from the American Diabetes Association 81st Scientific Sessions, and how we'll be keeping you updated! #JDRFxADA #ADA2021

JDRF's Vice President of Research, Dr. Sanjoy Dutta shares what you can expect to learn from The American Diabetes Association's 81st annual Scientific Sessions and how we'll be keeping you updated. #JDRFxADA #ADA2021

Adriana Migliorini discusses her work, which is focused around understanding immune cells and endocrine cells during human pancreatic development #JDRFxADA #ADA2021

Join us at 7pm ET for a Facebook Premiere event featuring key takeaways from Day 1 of The American Diabetes Association's Scientific Sessions. Tune in at facebook.com/myJDRF #JDRFxADA #ADA2021

Elad Sintov discusses his work focuses around building genetic modifications in stem cells as a replacement therapy for type 1 diabetes (T1D). #JDRFxADA #ADA2021

Check out our recap of Day 1 of the American Diabetes Association's Scientific Sessions at the link below! #JDRFxADA #ADA2021 ow.ly/rejm50Fj5OJ

Dr. Nikki Farnsworth discusses her research around beta cell death and how she's working to identify potential targets to help prevent beta cell death. #JDRFxADA #ADA2021

Good news for the T1D community: U.S. FDA has approved Semglee® as the first interchangeable biosimilar insulin product. Learn more at the blog: jdrf.org/blog/2021/07/2…

Last week, @JDRF and NIDDK brought together the top minds in immunology, material science, bioengineering, transplants and more to discuss keeping transplanted beta cells healthy through immune tolerance and localized immune modulation. Learn more: jdrf.org/blog/2021/08/0…

JDRF mourns the loss of T1D researcher Stacey Anderson, M.D. Read about her many contributions to the T1D here: jdrf.org/blog/2021/10/0…

Vertex VX-880 shows promising data from its Phase 1/2 Clinical Trial, including a 91% reduction in daily insulin requirement after 90 days. Learn more: jdrf.org/blog/2021/10/1…

BREAKING NEWS! A CDC advisory committee voted 14-0 recommending the use of the Pfizer/BioNTech COVID-19 vaccine in children ages 5-11. The CDC Director will soon make a recommendation on behalf of the CDC. Stay tuned for more details!